| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3956210 | Journal of Minimally Invasive Gynecology | 2014 | 23 Pages |
Abstract
ESS505, a modification to the commercially available ESS305 designed to cause immediate tubal occlusion, demonstrated a high rate of both immediate-term and intermediate-term tubal occlusion. Early tubal occlusion may obviate the need for interim alternative contraceptive methods after ESSURE placement.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
John MD, Darrien MD, Daniel J. MD,